TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
e-Therapeutics PLC |
2 Reason for the notification (please tick the appropriate box or boxes): |
|
An acquisition or disposal of voting rights |
✓ |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
An event changing the breakdown of voting rights |
|
Other (please specify): |
|
3. Full name of person(s) subject to the notification obligation: iii |
Rupert Labrum |
4. Full name of shareholder(s) (if different from 3.): iv |
|
5. Date of the transaction and date on which the threshold is crossed or reached: v |
16/08/2019 |
6. Date on which issuer notified: |
20/08/2019 |
7. Threshold(s) that is/are crossed or reached: vi, vii |
4.00% |
8. Notified details: |
|||||||
A: Voting rights attached to shares viii, ix |
|||||||
Class/type of shares |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
|||||
if possible using the ISIN CODE |
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x |
||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
|||
GB00B2823H99 |
12015000 |
12015000 |
12015000 |
12015000 |
|
4.46% |
|
B: Qualifying Financial Instruments |
||||
Resulting situation after the triggering transaction |
||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
instrument |
date xiii |
Conversion |
rights that may be |
rights |
|
|
Period xiv |
acquired if the |
|
|
|
|
instrument is |
|
|
|
|
exercised/ |
|
|
|
|
converted. |
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||
Resulting situation after the triggering transaction |
||||||
Type of financial instrument |
Exercise price |
Expiration date xvii |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to |
% of voting rights xix, xx |
|
|
|
|
|
|
Nominal |
Delta |
|
|
Total (A+B+C) |
|
Number of voting rights |
Percentage of voting rights |
1201500 |
4.46% |
|
|
|
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
|
|
|
Proxy Voting: |
|
10. Name of the proxy holder: |
|
11. Number of voting rights proxy holder will cease to hold: |
|
12. Date on which proxy holder will cease to hold voting rights: |
|
13. Additional information: |
|
14. Contact name: |
Rupert Labrum |
15. Contact telephone number: |
|